Next Article in Journal
Combined Exoscopic and Endoscopic Two-Step Keyhole Approach for Intracranial Meningiomas
Previous Article in Journal
Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation
 
 
Comment

A Case for Offering HPV Self-Sampling to Well-Screened Women. Comment on Lesack et al. Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results. Curr. Oncol. 2022, 29, 3860–3869

1
Department of Family Medicine, University of Alberta, Edmonton, AB T6G 2T4, Canada
2
Department of Family and Community Medicine, University of Toronto, Toronto, ON M5G 1V7, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2022, 29(8), 5368-5369; https://doi.org/10.3390/curroncol29080425
Received: 29 June 2022 / Accepted: 22 July 2022 / Published: 29 July 2022
(This article belongs to the Section Gynecologic Oncology)
Lesack et al. recently published a cross-sectional study that focused on human papillomavirus (HPV) self-sampling in the screened population, a population not conventionally thought of for HPV self-sampling. They found 52% of well-screened, highly educated women who participated in the Human Papillomavirus For Cervical Cancer (HPV FOCAL) screening trial in British Columbia, Canada, would be willing to self-collect an HPV sample. We published a similar study in 2021 on well-screened, highly educated women affiliated with a family medicine clinic in Edmonton, Alberta, Canada, and found that 60% of these women preferred to have the option of HPV self-sampling. Our findings reinforce Lesack et al.’s results and together provide evidence for offering HPV self-sampling as an option for the well-screened population. View Full-Text
Keywords: human papillomavirus; HPV; HPV self-sampling; HPV testing for cervix screening; attitudes and acceptance toward HPV self-sampling human papillomavirus; HPV; HPV self-sampling; HPV testing for cervix screening; attitudes and acceptance toward HPV self-sampling
MDPI and ACS Style

Kraut, R.; Manca, D.; Lofters, A.; Babenko, O. A Case for Offering HPV Self-Sampling to Well-Screened Women. Comment on Lesack et al. Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results. Curr. Oncol. 2022, 29, 3860–3869. Curr. Oncol. 2022, 29, 5368-5369. https://doi.org/10.3390/curroncol29080425

AMA Style

Kraut R, Manca D, Lofters A, Babenko O. A Case for Offering HPV Self-Sampling to Well-Screened Women. Comment on Lesack et al. Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results. Curr. Oncol. 2022, 29, 3860–3869. Current Oncology. 2022; 29(8):5368-5369. https://doi.org/10.3390/curroncol29080425

Chicago/Turabian Style

Kraut, Roni, Donna Manca, Aisha Lofters, and Oksana Babenko. 2022. "A Case for Offering HPV Self-Sampling to Well-Screened Women. Comment on Lesack et al. Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results. Curr. Oncol. 2022, 29, 3860–3869" Current Oncology 29, no. 8: 5368-5369. https://doi.org/10.3390/curroncol29080425

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop